Balaxi Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
Balaxi Pharmaceuticals has a total shareholder equity of ₹2.0B and total debt of ₹176.6M, which brings its debt-to-equity ratio to 8.8%. Its total assets and total liabilities are ₹2.6B and ₹569.8M respectively. Balaxi Pharmaceuticals's EBIT is ₹419.9M making its interest coverage ratio 25. It has cash and short-term investments of ₹622.9M.
Key information
8.8%
Debt to equity ratio
₹176.61m
Debt
Interest coverage ratio | 25x |
Cash | ₹622.91m |
Equity | ₹2.01b |
Total liabilities | ₹569.80m |
Total assets | ₹2.58b |
Recent financial health updates
Balaxi Pharmaceuticals (NSE:BALAXI) Has A Pretty Healthy Balance Sheet
Feb 09Is Balaxi Pharmaceuticals (NSE:BALAXI) A Risky Investment?
Aug 08Recent updates
Balaxi Pharmaceuticals Limited's (NSE:BALAXI) Share Price Could Signal Some Risk
May 29Market Might Still Lack Some Conviction On Balaxi Pharmaceuticals Limited (NSE:BALAXI) Even After 38% Share Price Boost
Feb 10Balaxi Pharmaceuticals (NSE:BALAXI) Has A Pretty Healthy Balance Sheet
Feb 09Is Balaxi Pharmaceuticals (NSE:BALAXI) A Risky Investment?
Aug 08The Trend Of High Returns At Balaxi Pharmaceuticals (NSE:BALAXI) Has Us Very Interested
May 20A Look At The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)
Feb 03Calculating The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)
Sep 06Balaxi Pharmaceuticals (NSE:BALAXI) Knows How To Allocate Capital Effectively
Jun 03Is Weakness In Balaxi Pharmaceuticals Limited (NSE:BALAXI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Mar 12Is Balaxi Pharmaceuticals Limited's(NSE:BALAXI) Recent Stock Performance Tethered To Its Strong Fundamentals?
Nov 27Financial Position Analysis
Short Term Liabilities: BALAXI's short term assets (₹2.1B) exceed its short term liabilities (₹542.0M).
Long Term Liabilities: BALAXI's short term assets (₹2.1B) exceed its long term liabilities (₹27.8M).
Debt to Equity History and Analysis
Debt Level: BALAXI has more cash than its total debt.
Reducing Debt: BALAXI's debt to equity ratio has increased from 0% to 8.8% over the past 5 years.
Debt Coverage: BALAXI's debt is well covered by operating cash flow (27.6%).
Interest Coverage: BALAXI's interest payments on its debt are well covered by EBIT (25x coverage).